Episode
Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
- Podcast
- Breast Cancer Update
- Published
- Mar 2, 2026
- Duration seconds
- 3520
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/antibody-drug-conjugates-for-breast-cancer-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/breast-cancer-update-757579/antibody-drug-conjugates-for-breast-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Sara M Tolaney from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data with antibody-drug conjugates in the management of breast cancer. CME information and select publications here .